2019 Impact & Innovation Awardee

Robert L. Masson, MD, FACS
Masson Spine Institute
Impact & Innovation Award: For outstanding leadership in pioneering the transformation of traditional bone marrow donation

ACCELERATING CRITICAL INNOVATION: TRANSFORMING BONE MARROW DONATION

​

Be The Match has the opportunity and obligation to save lives. Unfortunately, half of the time, donors say no when they are called. This is not good enough for our patients. One of the top myths about marrow donation is a fear of pain.

We are excited to share, for the first time, a major, cutting-edge Be The Match initiative: transforming traditional bone marrow donation.

Pioneered in partnership with world-renowned neurosurgeon, Dr. Robert Masson—we will learn how these advances are poised to transform the experience of our donors, ensuring thousands more say yes when they are called. Ultimately, transforming the traditional bone marrow donation experience is the catalyst for exponentially increasing outcomes for thousands more patients.

We will celebrate as we honor Dr. Masson with an Impact and Innovation Award for his incredible leadership, together raising funds that will support this transformational initiative.

2019 Amy Scholar Awardees

Tessa M. Andermann, MD, MPH

Stanford
Modulation of CAR-T Cell Therapy  Efficacy by the Intestinal Microbime in Patients with Leukemia and Lymphoma (clinical)

Noha Sharafeldin, MBBCh, MSc, PhD

University of Alabama
Impact of cognitive training on cognition after allogenic hematopoietic cell transplantation – a randomized wait-listed clinical trail (clinical)

Pavan Bachireddy, MD

Dana-Farber Cancer Institute
Coevolution of leukemia and immune cells during GvL response and resistance (pre-clinical)

Nathan Singh, MD

University of Pennsylvania
Molecular interactions between T cells and tumor cells that limit CAR-T cell cytotoxicity and persistence (pre-clinical)

AMY STRELZER MANASEVIT RESEARCH PROGRAM
Be The Match is committed to equalizing outcomes for all patients, even after transplant. The Amy Program focuses on finding prevention and treatment solutions for post-cell therapy complications like Graftversus- Host-Disease (GVHD) and infection that can threaten the survival of our patients.

Honoring our 2019 Amy Scholars
During this special evening, we are thrilled for the opportunity to award each of our four 2019 Amy Strelzer Manasevit Research Scholars with a $400,000, five-year grant to support their critical research studying prevention and treatment solutions.

Thank You to our Amy Program Mission Partners
These awards are only made possible through philanthropy. We will highlight some of our top mission partners whose generosity enables us to support the Amy Scholars’ discoveries that help prevent and treat post-cell therapy complications and improve treatment outcomes for our patients.